Growth Metrics

Scholar Rock Holding (SRRK) Total Liabilities (2017 - 2026)

Scholar Rock Holding's quarterly Total Liabilities came in at $259.2 million in Q1 2026, up 172.25% year-on-year from $95.2 million in Q1 2025, and up 63.27% quarter-over-quarter from $158.8 million in Q4 2025.

Scholar Rock Holding has reported Total Liabilities for 10 years, with the latest figure at $259.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Liabilities rose 172.25% year-over-year to $259.2 million; the trailing twelve-month figure through Mar 2026 stood at $259.2 million (up 172.25% YoY), and the FY2025 full-year result was $158.8 million, up 49.39% from the prior year.
  • Total Liabilities for Q1 2026 stood at $259.2 million, up from $158.8 million in the prior quarter.
  • The five-year high for Total Liabilities was $259.2 million in Q1 2026, with the low at $82.4 million in Q2 2023.
  • Average Total Liabilities over 5 years is $111.3 million, with a median of $95.2 million recorded in 2025.
  • Year-over-year, Total Liabilities retreated 26.02% in 2022 and jumped 172.25% in 2026.
  • Tracing SRRK's Total Liabilities over 5 years: stood at $97.9 million in 2022, then dropped by 12.37% to $85.8 million in 2023, then rose by 23.85% to $106.3 million in 2024, then soared by 49.39% to $158.8 million in 2025, then soared by 63.27% to $259.2 million in 2026.
  • The last three Total Liabilities figures came in at $259.2 million (Q1 2026), $158.8 million (Q4 2025), and $166.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.74 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 731.60 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 177.22 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 19.51 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.12 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 10.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.45 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 259.24 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 259.24 Mn
Dec 31, 2025 158.78 Mn
Sep 30, 2025 166.72 Mn
Jun 30, 2025 106.75 Mn
Mar 31, 2025 95.22 Mn
Dec 31, 2024 106.29 Mn
Sep 30, 2024 99.94 Mn
Jun 30, 2024 93.25 Mn
Mar 31, 2024 84.51 Mn
Dec 31, 2023 85.82 Mn
Sep 30, 2023 83.02 Mn
Jun 30, 2023 82.40 Mn
Mar 31, 2023 86.07 Mn
Dec 31, 2022 97.93 Mn
Sep 30, 2022 97.04 Mn
Jun 30, 2022 94.62 Mn
Mar 31, 2022 94.66 Mn
Dec 31, 2021 132.37 Mn
Sep 30, 2021 111.13 Mn
Jun 30, 2021 115.40 Mn
Mar 31, 2021 120.05 Mn
Dec 31, 2020 127.54 Mn
Sep 30, 2020 100.44 Mn
Jun 30, 2020 74.19 Mn
Mar 31, 2020 77.06 Mn
Dec 31, 2019 83.48 Mn
Sep 30, 2019 66.75 Mn
Jun 30, 2019 67.96 Mn
Mar 31, 2019 73.46 Mn
Dec 31, 2018 74.71 Mn
Sep 30, 2018 6.68 Mn
Jun 30, 2018 7.37 Mn
Mar 31, 2018 61.93 Mn
Dec 31, 2017 5.93 Mn